米国の糖尿病治療機器市場：Medtech 360

米国の糖尿病治療機器の市場は、同分野における新技術や革新的な製品の導入に加え、特に2型糖尿病患者の適応拡大を伴う新製品のFDA承認が追い風となり、予測期間中に力強い成長を遂げると考えられています。特に、CGM機器は、2型糖尿病患者に対するMedicareの適用範囲の拡大やOTC承認により、患者アクセスが向上し、急速な拡大が見込まれています。

米国の糖尿病治療機器市場は2033年まで力強く成長します。

• 製品セグメント別の成長はどのように異なるか？
• 市場拡大の要因は何か？

糖尿病治療機器分野では、複数の製造業者が新製品開発のために提携関係を結んでいます。

• 具体的にどの製造業者がこのような提携を結んでいるか？
• このような提携により、糖尿病治療機器のどの分野が最も大きく進歩しそうか？

糖尿病治療機器は、より幅広い2型糖尿病患者への使用が承認されつつあります。

• どの製品タイプが2型糖尿病患者向けの承認を取得してるか？
• 承認拡大は市場全体にどのような影響を与えるか？

GLP-1受容体作動薬は近年、米国の患者層で採用が拡大しています。

• GLP-1受容体作動薬の採用は米国の糖尿病治療機器市場にどのような影響を与えるか？
• GLP-1受容体作動薬の普及により、どの市場セグメントがより大きな影響を受けるか？

予測期間内に数多くの新規企業がこの分野に参入すると予想されます。

• これらはどのような企業で、どのような製品を市場に投入するか？
• 競合参入が最も多いセグメントは？

インスリンデリバリーデバイス市場は規模が大きく、今後も急速に拡大すると思われます。

• この分野ではどのような新機軸が生まれているか？
• この市場の成長を促進する要因は何か？
• どのタイプのデバイスが最も強く採用されているか、またこれらの動向は他の製品セグメントにどのような影響を与えているか？

当レポートでは、2019年から2033年までの米国の糖尿病治療機器市場の状況に関する包括的なデータと分析を提供します。

目次

米国

概要

エグゼクティブサマリー

• COVID-19の最新情報
• 市場ハイライト
• 競合ハイライト
• 市場動向
• 対象製品

主要なレポートの更新

糖尿病治療機器市場

• 市場のハイライト
• 市場の定義
• 市場予測データ
• 市場シェア
• 競合考察
  • Eli Lilly
  • Novo Nordisk
  • Sanofi
  • Dexcom
  • Abbott Laboratories
  • Insulet
  • Medtronic
  • その他の主な競合企業
  • すべての競合企業に影響を与える要因
• 市場動向

血糖測定デバイス市場

• 市場のハイライト
• 市場の定義
• 市場予測データ
  • 自己血糖測定デバイス
  • 持続血糖測定デバイス
• 市場シェア
• 競合考察
  • 競合上の考察
  • すべての競合企業に影響を与える要因

インスリン投与デバイス市場

• 市場のハイライト
• 市場の定義
• 市場予測データ
  • 頻回注射 (multiple daily injection：MDI) デバイス
  • インスリンポンプ
    • 従来型ポンプと付属品
    • パッチポンプ
• 市場シェア
• 競合考察
  • 競合上の考察
  • すべての競合企業に影響を与える要因

付録

調査手法

The US diabetes care device market will see strong growth over the forecast period, fueled by FDA approvals for new products with expanded indications-especially for the broader type 2 diabetes population-as well as the introduction of new technologies and innovative products in the diabetes care device space. Notably, the CGM device segment will witness rapid expansion, driven by increased Medicare coverage and over-the-counter approvals for the type 2 diabetes population, thereby enhancing patient access to these devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2033.

The US diabetes care device market will grow strongly through 2033.

• How will growth vary between product segments?
• What are the factors driving market expansion?

Several manufacturers within the diabetes care device space are entering into partnership for the development of new products.

• Which specific manufacturers are forming these partnerships?
• With these collaborations, what areas of diabetes care devices are likely to see the most significant advancements?

Diabetes care devices are getting approved for use by a wider range of people with type 2 diabetes.

• Which product segments have received approvals for type 2 diabetes population?
• How will expanded approvals impact the overall market?

GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.

• How will adoption of GLP-1 receptor agonists affect the US diabetes care device market?
• Which market segments will be more impacted by the growing popularity of GLP-1 receptor agonists?

Numerous new competitors are expected to enter this space within the forecast period.

• Who are these competitors and what products are they bringing to the market?
• Which segments are seeing the most incoming competitors?

The insulin delivery device market is large and will continue to expand rapidly.

• What are new innovations are emerging in this segment?
• What factors are driving growth in this market?
• Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?

Table of Contents

United States

Abstract

Executive Summary

• COVID-19 Updates
• Market Highlights
• Competitive Highlights
• Market Developments
• Products Covered

Key Report Updates

Diabetes Care Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Eli Lilly
  • Novo Nordisk
  • Sanofi
  • Dexcom
  • Abbott Laboratories
  • Insulet
  • Medtronic
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

Glucose Monitoring Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Self-Monitoring Blood Glucose Devices
  • Continuous Glucose Monitoring Devices
• Market Shares
• Competitive Insights
  • US Glucose Monitoring Device Market Competitive Insights
  • Factors Affecting All Competitors

Insulin Delivery Device Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Multiple Daily Injection Devices
  • Insulin Pumps
    • Conventional Pumps and Accessories
    • Patch Pumps
• Market Shares
• Competitive Insights
  • US Insulin Delivery Device Market Competitive Insights
  • Factors Affecting All Competitors

Appendix

• Abbreviations
• Bibliography

Methodology

• Core Country Coverage Methodology
• Research Methodology
• Marketrack Methodology
• PriceTrack Methodology
• Forecast Methodology
• Supplemental Country Coverage Methodology
• Base-Year Ratio Analysis
• Market Forecasting

Tables and Figures

• Diabetes Care Device Market, by Product Type, US (USD), 2019-2033
• Diabetes Care Device Market Landscape, US (USD), 2023 and 2033
• Diabetes Care Device Market Leaders, by Product Type and Revenue, US, 2023
• Competitive Insights
• Companies Mentioned
• Recent Events in the Diabetes Care Device Market, US
• Key Clinical Trials in the Diabetes Care Device Market, US
• Emerging Products for the Diabetes Care Device Market, US
• Diabetes Care Devices Covered, US
• US Diabetes Care Device Market Drivers
• US Diabetes Care Device Market Limiters
• Diabetes Care Device Market, by Product Type, US (USD), 2019-2033
• Diagnosed Prevalent Drug-Treated Diabetes Patients, by Disease Type, US, 2019-2033
• Diabetes Care Device Market, by Product Type, US (USD), 2019-2033
• Diabetes Care Device Revenue Market Shares, US, 2023
• Diabetes Care Device Revenue Market Shares, by Product Type, US, 2023
• Eli Lilly Competitive Insights
• Novo Nordisk Competitive Insights
• Sanofi Competitive Insights
• Dexcom Competitive Insights
• Abbott Laboratories Competitive Insights
• Insulet Competitive Insights
• Medtronic Competitive Insights
• Competitive Insights for Other Key Competitors
• Recent Events in the Diabetes Care Device Market, US
• Key Clinical Trials in the Diabetes Care Device Market, US
• Emerging Products for the Diabetes Care Device Market, US
• US Glucose Monitoring Device Market Drivers
• US Glucose Monitoring Device Market Limiters
• Glucose Monitoring Device Market, by Product Type, US (USD), 2019-2033
• Glucose Monitoring Device Market, by Product Type, US (USD), 2019-2033
• SMBG Device Market, by Product Type, US (USD), 2019-2033
• SMBG Device Market Growth, by Product Type, US, 2020-2033
• CGM Device Market, by Product Type, US (USD), 2019-2033
• CGM Device Market Growth, by Product Type, US, 2020-2033
• Glucose Monitoring Device Revenue Market Shares, US, 2023
• Glucose Monitoring Device Revenue Market Shares, by Product Type, US, 2023
• US Insulin Delivery Device Market Drivers
• US Insulin Delivery Device Market Limiters
• Insulin Delivery Device Market, by Product Type, US (USD), 2019-2033
• Diagnosed Prevalent Diabetes Patients, by Treatment Type, US, 2019-2033
• Insulin Delivery Device Market, by Product Type, US (USD), 2019-2033
• MDI Device Market, by Product Type, US (USD), 2019-2033
• Insulin Syringe Market, US (USD), 2019-2033
• Insulin Pen and Accessory Market, by Product Type, US (USD), 2019-2033
• Insulin Pen and Accessory Market Growth, by Product Type, US, 2020-2033
• Insulin Pump Patients, by Product Type, US, 2019-2033
• Insulin Pump Market, by Product Type, US (USD), 2019-2033
• Insulin Delivery Device Revenue Market Shares, US, 2023
• Insulin Delivery Device Revenue Market Shares, by Product Type, US, 2023